At present, Royalty Pharma plc (RPRX) has a stock price of $33.07. In the previous session, the stock saw a rise, peaking at $33.65 after an opening price of $33.21. The day’s lowest price was $32.44, and it closed at $33.38.
Royalty Pharma plc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $44.66 on 08/17/22 and the lowest value was $32.67 on 05/23/23.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
52-week price history of RPRX Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Royalty Pharma plc’s current trading price is -25.95% away from its 52-week high, while its distance from the 52-week low is 1.21%. The stock’s price range during this period has spanned from $32.67 to $44.66. In the Healthcare sector, the Royalty Pharma plc’s shares surpassed a trading volume of approximately 3.41 million for the day, which was noticeably higher compared to the average daily volume of 9.1.92 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Royalty Pharma plc (RPRX) has experienced a quarterly decline of -10.96% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 20.03B and boasts a workforce of 75 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 36.44, with a change in price of -6.10. Similarly, Royalty Pharma plc recorded 1,817,893 in trading volume during the last 100 days, posting a change of -15.57%.
Examining RPRX’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for RPRX stands at 1.20. Similarly, the long-term debt-to-equity ratio is also 1.03.
RPRX Stock Stochastic Average
Today, Royalty Pharma plc’s raw stochastic average for the past 50 days stands at 10.96%, indicating a decline from the raw stochastic average of the last 20 days, which was 18.98%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 23.32% and 23.09% respectively.
RPRX Stock Price Performance Analysis
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. Year to date metric has recorded a loss of -16.32%.However, over the last six months, we can see a stronger performance of -22.86%. Over the last 30 days, the price of RPRX has leaped by -7.70%. And in the last five days, it has fallen by -0.48%.